Registration is free to all interested participants. Deadline for abstract submission is November 28 and for registration deadline is December 3.Non-local prospective attendees: feel free to contact the organizers about accommodation options.

Download the program here: Chemical Systems Biology Symposium

Register here: https://elomake.helsinki.fi/lomakkeet/46410/lomake.htm

Session I:

9:10-9:40       Stefan Knapp (SGC Oxford, UK)

Selective targeting of protein interactions mediated by epigenetic effector domains

9:40-10:10     Bernhard Kuster (Technical University of Munich, Germany)

Chemical proteomics for target discovery, drug selectivity profiling, drug mechanism of action and resistance formation

10:10-10:40   Lars Zender (University Hospital Tübingen, Germany)

Direct in vivo RNAi screening for an accelerated cancer gene discovery in gastrointestinal tumors

10:40-11:00   Coffee break

Session II:

11:00-11:30   Stefan Kubicek (CeMM Research Center for Molecular Medicine, Austria)

Screening for drug-drug interactions with a library of unique compounds

11:30-12:00   Krister Wennerberg (FIMM, University of Helsinki, Finland)

Personalized cancer therapy guided by drug sensitivity testing and Integrated Systems Medicine

12:00-12:30   Eric Tang (AstraZeneca, UK)

Finding novel clinical relevant combinations using High Throughput Combination profiling across cell panels

12:30-13:30   Lunch

Session III:

13:30-14:00   Risto Kerkelä (University of Oulu, Finland)

Mechanisms of cardiotoxicity

14:00-14:30   Mikko Niemi (University of Helsinki, Finland)

TBA

14:30-15:00   Short talks chosen from abstracts

15:00-16:00   Coffee break and poster session

Session IV:

16:00-16:30   Mathew Garnett (Wellcome Trust Sanger Institute, UK)

Exploring the genomic landscape of human cancer to identify biomarkers of drug response

16:30-17:00   Julio Saez-Rodriguez (EMBL-EBI, UK)

Computational models to predict and understand drug sensitivity in cancer

17:00-17:30   Panel discussion